James Ballenger to Panic
This is a "connection" page, showing publications James Ballenger has written about Panic.
Connection Strength
1.392
-
Effect of alprazolam on depression in panic disorder. J Clin Psychopharmacol. 1991 Apr; 11(2):145-6.
Score: 0.089
-
Long-term pharmacologic treatment of panic disorder. J Clin Psychiatry. 1991 Feb; 52 Suppl:18-23; discussion 24-5.
Score: 0.088
-
Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry. 1991 Feb; 52 Suppl:26-31; discussion 32.
Score: 0.088
-
Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry. 1990 Nov; 51(11):456-8.
Score: 0.086
-
Efficacy of benzodiazepines in panic disorder and agoraphobia. J Psychiatr Res. 1990; 24 Suppl 2:15-25.
Score: 0.081
-
Phenelzine treatment of panic disorder: lack of effect on pyridoxal phosphate levels. J Clin Psychopharmacol. 1989 Dec; 9(6):428-31.
Score: 0.081
-
Depression in patients receiving lorazepam for panic. Am J Psychiatry. 1989 Sep; 146(9):1230-1.
Score: 0.080
-
Three cases of panic disorder with agoraphobia in children. Am J Psychiatry. 1989 Jul; 146(7):922-4.
Score: 0.079
-
Toward an integrated model of panic disorder. Am J Orthopsychiatry. 1989 Apr; 59(2):284-93.
Score: 0.077
-
Possible relationship of bowel obsessions to panic disorder with agoraphobia. Am J Psychiatry. 1988 Oct; 145(10):1324-5.
Score: 0.075
-
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry. 1988 May; 45(5):413-22.
Score: 0.072
-
Unrecognized prevalence of panic disorder in primary care, internal medicine and cardiology. Am J Cardiol. 1987 Dec 28; 60(18):39J-47J.
Score: 0.071
-
Antidepressants in panic disorder and agoraphobia. J Affect Disord. 1987 Sep-Oct; 13(2):153-68.
Score: 0.069
-
Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry. 1986 Sep; 47(9):470-3.
Score: 0.065
-
Pharmacotherapy of the panic disorders. J Clin Psychiatry. 1986 Jun; 47 Suppl:27-32.
Score: 0.063
-
Biological aspects of panic disorder. Am J Psychiatry. 1986 Apr; 143(4):516-8.
Score: 0.063
-
Sequence of improvement in agoraphobia with panic attacks. J Psychiatr Res. 1990; 24(1):1-8.
Score: 0.020
-
CSF prostaglandin-E in agoraphobia with panic attacks. Biol Psychiatry. 1989 Jul; 26(3):257-64.
Score: 0.020
-
Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord. 1989 Jan-Feb; 16(1):49-58.
Score: 0.019
-
Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry. 1988 Nov; 39(11):1157-65.
Score: 0.019
-
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry. 1988 May; 45(5):423-8.
Score: 0.018
-
Alprazolam in the treatment of social phobia. J Clin Psychiatry. 1988 Jan; 49(1):17-9.
Score: 0.018
-
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry. 1987 May; 144(5):664-5.
Score: 0.017
-
The dexamethasone suppression test in agoraphobia. J Clin Psychopharmacol. 1985 Apr; 5(2):100-2.
Score: 0.015
-
Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71.
Score: 0.014
-
CSF diazepam-binding inhibitor concentrations in panic disorder. Biol Psychiatry. 1992 Oct 15; 32(8):712-6.
Score: 0.006